Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Use of Large Language Models and Artificial Intelligence Tools in Works Submitted to <i>Journal of Clinical Oncology</i>
13
Zitationen
7
Autoren
2023
Jahr
Abstract
We don't want to change.Every change is a menace to stability.That's another reason why we're so chary of applying new inventions.-Aldous Huxley, Brave New WorldThe Journal of Clinical Oncology shares knowledge and expertise, fosters a robust interchange, and perpetuates valuable learning, all in service of improving outcomes of patients with cancer.To that end, JCO is more than just a collection of articles.The journal provides a forum for the exchange of ideas in which individual voices contribute their unique perspective and experience, providing the human context to the knowledge generated.That conversation between the author and the reader, albeit distant in time and space, is central to our purpose.Authors create text to provide the background and rationale for their work, describe the methods, delineate results, and share their interpretation.Figures display data visually, complementing and extending the results that were given in text form.Authors routinely use electronic tools to search the literature, correct grammar and spelling, analyze data, and format references.Recent advances in large language models (LLMs) and artificial intelligence (AI) such as ChatGPT have greatly expanded the electronic assistance available to authors.JCO's believes in the power of research to eliminate suffering from cancer.The potential for LLMs and AI to advance the pace of scientific development is both real and powerful; with great power comes even greater responsibility.A tool with such capabilities should be used thoughtfully and carefully.JCO recognizes that authors may find utility in using AI/LLMs in their scientific writing.However, LLMs/AI tools cannot and should not replace the human reasoning that is essential to our understanding of the world.Accordingly, we offer specific guidance on the appropriate use of these tools for manuscripts submitted to JCO.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.795 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.500 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.736 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.101 Zit.
Autoren
Institutionen
- Bristol-Myers Squibb (Germany)(DE)
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- American Society of Clinical Oncology(US)
- Indiana University Health(US)
- Indiana University – Purdue University Indianapolis(US)
- Astex Pharmaceuticals
- Dana-Farber Cancer Institute(US)
- University of Rochester Medical Center(US)
- University of North Carolina at Chapel Hill(US)
- City of Hope(US)